Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Kidney Precision Medicine Project Tissue Interrogation…

U.S. National Institutes of Health·United States of America

Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)

Closes 7/10/2026$1M – $6MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This Notice of Funding Opportunity (NOFO) requests applications for Kidney Precision Medicine Project (KPMP) Tissue Interrogation Sites (TIS) to analyze human kidney tissue. The TIS will collaborate with the Recruitment Sites (RS), Kidney Tissue Atlas Coordinating Center (KTACC), and Central Hub (CH) to obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) or chronic kidney disease (CKD), create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. The key aspects of this opportunity include: • The TIS will use highly integrated multi-modal analytic pipelines to interrogate human kidney biopsy tissue. • The project aims to discover and define new disease pathways and subgroups that enable precision clinical trials. • All KPMP personnel will actively participate in scientific discovery and promote open science. • The funding opportunity announcement includes a Data Management and Sharing Plan, which is required for any NIH-funded or conducted research that will generate scientific data.

Attached files

Contact

Debbie S. Gipson(Scientific/Research Contact)

[email protected]

(301) 480-2268

Key dates

Opened
9/10/2025
Closes
7/10/2026
Projected award
4/1/2027
Duration
5 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-DK-27-302

Budget estimate

$1,000,000 – $6,000,000

The estimated funding for this opportunity is $6,000,000, with an award ceiling of $1,500,000. The actual budget may vary depending on the number of awards made and the specific proposals submitted. The funding will support the Kidney Precision Medicine Project Tissue Interrogation Sites, and the budget may be influenced by factors such as the number of participants, the complexity of the research, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 70%

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

69% match

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

Closes 11/6/2026Opened 9/30/2025

U.S. National Institutes of Health·United States of America

68% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

68% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

68% match

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Closes 1/6/2028Opened 12/22/2021

U.S. National Institutes of Health·United States of America

68% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

68% match

Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Closes 5/26/2028Opened 12/10/2025

U.S. National Institutes of Health·United States of America

68% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

68% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. National Institutes of Health·United States of America

68% match

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

Closes 11/9/2026Opened 9/3/2025

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

68% match

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Closes 3/9/2027Opened 8/4/2026

U.S. National Institutes of Health·United States of America

67% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

67% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

67% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Food and Drug Administration·United States of America

67% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

67% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

67% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. Food and Drug Administration·United States of America

67% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Food and Drug Administration·United States of America

67% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

67% match

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Closes 1/25/2028Opened 6/17/2025

U.S. National Institutes of Health·United States of America

67% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. National Institutes of Health·United States of America

67% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026